Insulin Manufacturers Employ Strategies to Extend Market Exclusivity
TUESDAY, Nov. 21, 2023 -- Insulin manufacturers have employed strategies to extend periods of market exclusivity on brand-name insulin products, including filing patents after U.S. Food and Drug Administration approval, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2023 Category: Pharmaceuticals Source Type: news
Midlife belly fat linked to increased Alzheimer's risk
People with higher amounts of visceral abdominal fat in midlife may be at increased risk of Alzheimer's disease, according to research to be presented at the upcoming RSNA meeting.This type of adipose tissue -- which surrounds internal organs deep in the belly -- is linked to changes in the brain up to 15 years before the earliest Alzheimer's symptoms appear, reported a team led by Mahsa Dolatshahi, MD, of Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis."[Our] findings prompt designing interventions targeted at reducing abdominal visceral fat, obesity, and insulin resistance in ...
Source: AuntMinnie.com Headlines - November 20, 2023 Category: Radiology Authors: Kate Madden Yee Tags: 2023 Source Type: news
Short Sleep Duration Impairs Insulin Sensitivity in Women
FRIDAY, Nov. 17, 2023 -- Short sleep duration for six weeks impairs insulin sensitivity in women, according to a study published online Nov. 15 in Diabetes Care.Faris M. Zuraikat, Ph.D., from the Columbia University Irving Medical Center in New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2023 Category: Pharmaceuticals Source Type: news
How Drug Makers Manipulate Patents to Keep Insulin Prices High
The financial burden of high insulin costs that patients and insurers face is often blamed on the Food and Drug Administration’s (FDA) regulatory framework, but a new study suggests pharmaceutical companies have also been using patenting processes to unfairly maintain high costs. In the FDA’s master list of approved medications, devices, and other therapeutics, a document known as the Orange Book, patent ownership of each item governs which companies are allowed to manufacture and sell which therapies. The FDA deals with drug approval, but patents are granted by another agency entirely, the U.S. Patent and Trad...
Source: TIME: Health - November 17, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Insulin Delivery Device Patents Prolong Market Exclusivity Insulin Delivery Device Patents Prolong Market Exclusivity
In a new data analysis, Harvard researchers find that insulin manufacturers have filed multiple patents on delivery devices following the original insulin product approval.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 16, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
GLP-1 Drugs Reduced Patient A1c Levels, Need for Other Drugs GLP-1 Drugs Reduced Patient A1c Levels, Need for Other Drugs
In some cases, the addition of GLP-1 agonists allowed clinicians to deprescribe other medications such as insulin and sulfonylureas.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2023 Category: Cardiology Tags: Family Medicine/Primary Care News Source Type: news
Chronic sleep deficiency increases insulin resistance in women, especially postmenopausal women
Findings highlight insufficient sleep as a modifiable risk factor for type 2 diabetes. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 14, 2023 Category: American Health Source Type: news
Too Little Sleep Might Raise a Woman's Odds for Diabetes
TUESDAY, Nov. 14, 2023 -- Women who don ’t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds.Shortening sleep by just 90 minutes increased insulin resistance in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2023 Category: General Medicine Source Type: news
Octopus-like sucker may mean the end of many jabs for diseases such as obesity and breast cancer
The patches have tiny rubber suction cups and are designed to be stuck on to the inside of the cheek, where they deliver insulin and other drugs for obesity and breast cancer, for instance. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2023 Category: Consumer Health News Source Type: news
Losing just 90 minutes of sleep a night can increase women's risk of this chronic disease... after just six WEEKS
Experts from Columbia University believe a lack of sleep can increase stress on insulin-producing cells, causing them to fail.
This can put women at greater risk of developing type 2 diabetes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2023 Category: Consumer Health News Source Type: news
Beyond insulin: Medi-Cal expands patient access to diabetes supplies
California's Medicaid program is making it easier for people with diabetes to obtain the supplies they need to manage their blood sugar. (Source: L.A. Times - Health)
Source: L.A. Times - Health - November 13, 2023 Category: Consumer Health News Authors: Angela Hart | KFF Health News Source Type: news
UnitedHealth to Add 8 Insulin Products to Reimbursement List UnitedHealth to Add 8 Insulin Products to Reimbursement List
UnitedHealth ' s pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket spend to $35 or less.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Science Reveals Link Between Obesity, Diabetes & Pancreatic Cancer Risk
FRIDAY, Nov. 10, 2023 -- Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer.In the study, scientists found excessive insulin levels... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 10, 2023 Category: General Medicine Source Type: news
FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet
Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet.
On Nov. 11, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the drug is already approved, in different doses, for type 2 diabetes, as Mounjaro, and its effectiveness in those patients is due in part to its weight loss effects.
[time-brightcove not-tgx=”true”]
About 70% of Americans are overweight, with a body mass index (BMI) between ...
Source: TIME: Health - November 9, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Ozempic Can ’ t Fix America ’ s Obesity Crisis
What is obesity?
Some people will tell you it’s a fancy word for being fat; others might say it’s a slur that pathologizes bigger bodies. And yet others will insist it’s a moral failing—one of laziness and poor willpower.
[time-brightcove not-tgx=”true”]
For the past decade, however, the medical community has recognized that obesity is a chronic disease, much like cancer, diabetes, and high blood pressure. Obesity triples the risk of hospitalization due to COVID-19, is linked with hundreds of medical complications, and accounts for 4 million preventable deaths every year.
Obesi...
Source: TIME: Health - November 8, 2023 Category: Consumer Health News Authors: Fatima Cody Stanford and Simar Bajaj Tags: Uncategorized freelance Source Type: news
